inTEST Reports Record Revenue of $32.6 Million for the 2023 Second Quarter with Net Earnings Growth of 32% Year-over-Year

inTEST CORPORATION

Consolidated Statements of Operations

(In thousands, except share and per share data)

(Unaudited)

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

32,558

 

 

$

29,571

 

 

$

64,477

 

 

$

53,652

 

Cost of revenue

 

 

17,528

 

 

 

16,023

 

 

 

34,395

 

 

 

29,091

 

Gross profit

 

 

15,030

 

 

 

13,548

 

 

 

30,082

 

 

 

24,561

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling expense

 

 

4,661

 

 

 

4,033

 

 

 

9,116

 

 

 

7,489

 

Engineering and product development expense

 

 

1,983

 

 

 

1,859

 

 

 

3,887

 

 

 

3,783

 

General and administrative expense

 

 

5,042

 

 

 

4,928

 

 

 

10,217

 

 

 

9,759

 

Total operating expenses

 

 

11,686

 

 

 

10,820

 

 

 

23,220

 

 

 

21,031

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income

 

 

3,344

 

 

 

2,728

 

 

 

6,862

 

 

 

3,530

 

Interest expense

 

 

(176

)

 

 

(141

)

 

 

(358

)

 

 

(278

)

Other income (expense)

 

 

197

 

 

(17

)

 

 

255

 

 

(27

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings before income tax expense

 

 

3,365

 

 

 

2,570

 

 

 

6,759

 

 

 

3,225

 

Income tax expense

 

 

572

 

 

 

454

 

 

 

1,149

 

 

 

532

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net earnings

 

$

2,793

 

 

$

2,116

 

 

$

5,610

 

 

$

2,693

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share - basic

 

$

0.25

 

 

$

0.20

 

 

$

0.51

 

 

$

0.25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

 

11,241,183

 

 

 

10,653,268

 

 

 

10,998,456

 

 

 

10,635,270

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per common share - diluted

 

$

0.24

 

 

$

0.20

 

 

$

0.49

 

 

$

0.25

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares and common share equivalents outstanding - diluted

 

 

11,696,569

 

 

 

10,814,799

 

 

 

11,392,617

 

 

 

10,828,696

 

inTEST CORPORATION

Consolidated Balance Sheets

(In thousands)

 

 

June 30,

 

 

December 31,

 

 

 

2023

 

 

2022

 

 

 

(Unaudited)

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

37,435

 

 

$

13,434

 

Restricted cash

 

 

-

 

 

 

1,142

 

Trade accounts receivable, net of allowance for credit losses of $501 and $496, respectively

 

 

21,581

 

 

 

21,215

 

Inventories

 

 

23,070

 

 

 

22,565

 

Prepaid expenses and other current assets

 

 

1,495

 

 

 

1,695

 

Total current assets

 

 

83,581

 

 

 

60,051

 

Property and equipment:

 

 

 

 

 

 

 

 

Machinery and equipment

 

 

6,779

 

 

 

6,625

 

Leasehold improvements

 

 

3,520

 

 

 

3,242

 

Gross property and equipment

 

 

10,299

 

 

 

9,867

 

Less: accumulated depreciation

 

 

(7,081

)

 

 

(6,735

)

Net property and equipment

 

 

3,218

 

 

 

3,132

 

Right-of-use assets, net

 

 

5,177

 

 

 

5,770

 

Goodwill

 

 

21,707

 

 

 

21,605

 

Intangible assets, net

 

 

17,613

 

 

 

18,559

 

Deferred tax assets

 

 

965

 

 

 

280

 

Restricted certificates of deposit

 

 

100

 

 

 

100

 

Other assets

 

 

496

 

 

 

569

 

Total assets

 

$

132,857

 

 

$

110,066

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

 

 

Current portion of Term Note

 

$

4,100

 

 

$

4,100

 

Current portion of operating lease liabilities

 

 

1,731

 

 

 

1,645

 

Accounts payable

 

 

5,735

 

 

 

7,394

 

Accrued wages and benefits

 

 

3,570

 

 

 

3,907

 

Accrued professional fees

 

 

1,010

 

 

 

884

 

Customer deposits and deferred revenue

 

 

5,176

 

 

 

4,498

 

Accrued sales commissions

 

 

1,202

 

 

 

1,468

 

Domestic and foreign income taxes payable

 

 

1,184

 

 

 

1,409

 

Other current liabilities

 

 

1,660

 

 

 

1,564

 

Total current liabilities

 

 

25,368

 

 

 

26,869

 

Operating lease liabilities, net of current portion

 

 

3,959

 

 

 

4,705

 

Term Note, net of current portion

 

 

9,992

 

 

 

12,042

 

Contingent consideration

 

 

1,063

 

 

 

1,039

 

Other liabilities

 

 

411

 

 

 

455

 

Total liabilities

 

 

40,793

 

 

 

45,110

 

Commitments and Contingencies

 

 

 

 

 

 

 

 

Stockholders' equity:

 

 

 

 

 

 

 

 

Preferred stock, $0.01 par value; 5,000,000 shares authorized; no shares issued or outstanding

 

 

-

 

 

 

-

 

Common stock, $0.01 par value; 20,000,000 shares authorized; 12,185,220 and 11,063,271 shares issued, respectively

 

 

122

 

 

 

111

 

Additional paid-in capital

 

 

53,296

 

 

 

31,987

 

Retained earnings

 

 

38,464

 

 

 

32,854

 

Accumulated other comprehensive earnings

 

 

470

 

 

 

218

 

Treasury stock, at cost; 38,514 and 34,308 shares, respectively

 

 

(288

)

 

 

(214

)

Total stockholders' equity

 

 

92,064

 

 

 

64,956

 

Total liabilities and stockholders' equity

 

$

132,857

 

 

$

110,066

 

 

inTEST CORPORATION

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

 

Six Months Ended
June 30,

 

 

 

2023

 

 

2022

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

Net earnings

 

$

5,610

 

 

$

2,693

 

Adjustments to reconcile net earnings to net cash provided by (used in) operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

2,350

 

 

 

2,528

 

Provision for excess and obsolete inventory

 

 

266

 

 

 

230

 

Foreign exchange (gain) loss

 

 

(47

)

 

 

98

 

Amortization of deferred compensation related to stock-based awards

 

 

1,079

 

 

 

923

 

Discount on shares sold under Employee Stock Purchase Plan

 

 

14

 

 

 

18

 

Loss on disposal of property and equipment

 

 

98

 

 

 

61

 

Deferred income tax benefit

 

 

(685

)

 

 

(805

)

Changes in assets and liabilities:

 

 

 

 

 

 

 

 

Trade accounts receivable

 

 

(372

)

 

 

(6,607

)

Inventories

 

 

(693

)

 

 

(4,894

)

Prepaid expenses and other current assets

 

 

212

 

 

(87

)

Other assets

 

 

2

 

 

(395

)

Operating lease liabilities

 

 

(849

)

 

 

(701

)

Accounts payable

 

 

(1,607

)

 

 

3,506

 

Accrued wages and benefits

 

 

(351

)

 

 

(981

)

Accrued professional fees

 

 

117

 

 

(471

)

Customer deposits and deferred revenue

 

 

625

 

 

(264

)

Accrued sales commissions

 

 

(266

)

 

 

219

 

Domestic and foreign income taxes payable

 

 

(220

)

 

 

(477

)

Other current liabilities

 

 

76

 

 

 

264

 

Other liabilities

 

 

(17

)

 

 

61

 

Net cash provided by (used in) operating activities

 

 

5,342

 

 

(5,081

)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Refund of final working capital adjustment related to Acculogic

 

 

-

 

 

 

371

 

Purchase of property and equipment

 

 

(709

)

 

 

(708

)

Purchase of short-term investments

 

 

-

 

 

(3,477

)

Net cash used in investing activities

 

 

(709

)

 

 

(3,814

)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Net proceeds from public offering of common stock

 

 

19,244

 

 

 

-

 

Repayments of Term Note

 

 

(2,050

)

 

 

(1,908

)

Proceeds from shares sold under Employee Stock Purchase Plan

 

 

83

 

 

 

103

 

Proceeds from stock options exercised

 

 

900

 

 

 

-

 

Acquisition of treasury stock-shares surrendered by employees to satisfy tax liability

 

 

(74

)

 

 

(10

)

Net cash provided by (used in) financing activities

 

 

18,103

 

 

(1,815

)

 

 

 

 

 

 

 

 

 

Effects of exchange rates on cash

 

 

123

 

 

 

58

 

 

 

 

 

 

 

 

 

 

Net cash provided by (used in) all activities

 

 

22,859

 

 

(10,652

)

Cash and cash equivalents at beginning of period

 

 

14,576

 

 

 

21,195

 

Cash and cash equivalents at end of period

 

$

37,435

 

 

$

10,543

 

 

 

 

 

 

 

 

 

 

Cash payments for:

 

 

 

 

 

 

 

 

Domestic and foreign income taxes

 

$

2,060

 

 

$

1,865

 

inTEST CORPORATION

Revenue by Market

(In thousands)

(Unaudited)

($ in 000s)

Three Months Ended

Change

Change

6/30/2023

6/30/2022

$

%

3/31/2023

$

%

Revenue

Semi

$18,833

57.8

%

$16,409

55.5

%

$2,424

 

14.8

%

$17,683

55.4

%

$1,150

 

6.5

%

Industrial

2,806

8.6

%

2,930

9.9

%

(124

)

-4.2

%

3,137

9.8

%

(331

)

-10.6

%

Auto/EV

1,542

4.7

%

3,594

12.2

%

(2,052

)

-57.1

%

2,597

8.1

%

(1,055

)

-40.6

%

Life Sciences

1,135

3.5

%

1,169

3.9

%

(34

)

-2.9

%

1,513

4.8

%

(378

)

-25.0

%

Defense/Aerospace

3,890

11.9

%

1,423

4.8

%

2,467

 

173.4

%

2,839

8.9

%

1,051

 

37.0

%

Security

936

2.9

%

794

2.7

%

142

 

17.9

%

966

3.0

%

(30

)

-3.1

%

Other

3,416

10.6

%

3,252

11.0

%

164

 

5.0

%

3,184

10.0

%

232

 

7.3

%

$32,558

100.0

%

$29,571

100.0

%

$2,987

 

10.1

%

$31,919

100.0

%

$639

 

2.0

%

 

Orders by Market

(In thousands)

(Unaudited)

($ in 000s)

Three Months Ended

Change

Change

6/30/2023

6/30/2022

$

%

3/31/2023

$

%

Orders

Semi

$14,721

46.9

%

$26,732

66.0

%

$(12,011

)

-44.9

%

$18,346

59.5

%

$(3,625

)

-19.8

%

Industrial

5,756

18.3

%

2,366

5.8

%

3,390

 

143.3

%

4,142

13.5

%

1,614

 

39.0

%

Auto/EV

3,276

10.4

%

2,750

6.8

%

526

 

19.1

%

2,044

6.6

%

1,232

 

60.3

%

Life Sciences

609

1.9

%

1,535

3.8

%

(926

)

-60.3

%

1,936

6.3

%

(1,327

)

-68.5

%

Defense/Aerospace

3,216

10.2

%

1,897

4.7

%

1,319

 

69.5

%

1,977

6.4

%

1,239

 

62.7

%

Security

456

1.5

%

989

2.4

%

(533

)

-53.9

%

212

0.7

%

244

 

115.1

%

Other

3,397

10.8

%

4,249

10.5

%

(852

)

-20.1

%

2,167

7.0

%

1,230

 

56.8

%

$31,431

100.0

%

$40,518

100.0

%

$(9,087

)

-22.4

%

$30,824

100.0

%

$607

 

2.0

 

%

 

inTEST CORPORATION

Segment Data

(In thousands)

(Unaudited)

 

Three Months Ended

June 30,

 

 

Six Months Ended

June 30

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Revenue:

 

 

 

 

 

 

 

 

 

 

 

Electronic Test

$ 10,993

 

 

$ 9,797

 

 

$ 21,364

 

 

$ 18,575

 

Environmental Technologies

8,136

 

 

7,507

 

 

16,178

 

 

14,500

 

Process Technologies

13,429

 

 

12,267

 

 

26,935

 

 

20,577

 

Total Revenue

$32,558

 

 

$ 29,571

 

 

$ 64,477

 

 

$ 53,652

 

 

 

 

 

 

 

 

 

 

 

 

 

Division operating income:

 

 

 

 

 

 

 

 

 

 

 

Electronic Test

$ 2,641

 

 

$ 2,193

 

 

$ 5,219

 

 

$ 4,080

 

Environmental Technologies

943

 

 

1,070

 

 

1,956

 

 

1,872

 

Process Technologies

2,592

 

 

2,569

 

 

5,268

 

 

3,299

 

Total division operating income

6,176

 

 

5,832

 

 

12,443

 

 

9,251

 

Corporate expenses

(2,309

)

 

(2,339

)

 

(4,514

)

 

(4,174

)

Acquired intangible amortization

(523

)

 

(765

)

 

(1,067

)

 

(1,547

)

Interest expense

(176

)

 

(141

)

 

(358

)

 

(278

)

Other income (expense)

197

 

 

(17

)

 

255

 

 

(27

)

Earnings before income tax expense

$ 3,365

 

 

$ 2,570

 

 

$ 6,759

 

 

$ 3,225

 

 

 

 

 

 

 

 

 

 

 

 

 

inTEST CORPORATION

Reconciliation of GAAP Measures to Non-GAAP Financial Measures

(In thousands, except per share and percentage data)

(Unaudited)

 

Reconciliation of Net Earnings to Adjusted Net Earnings (Non-GAAP) and

Earnings Per Diluted Share to Adjusted EPS (Non-GAAP):

Three Months Ended

6/30/2023

 

6/30/2022

 

3/31/2023

 

 

Net earnings

$

2,793

 

$

2,116

 

$

2,817

 

Acquired intangible amortization

 

523

 

 

765

 

 

544

 

Tax adjustments

 

(89

)

 

(162

)

 

(92

)

Adjusted net earnings (Non-GAAP)

$

3,227

 

$

2,719

 

$

3,269

 

 

Diluted weighted average shares outstanding

 

11,697

 

 

10,815

 

 

11,089

 

Earnings per diluted share:

Net earnings

$

0.24

 

$

0.20

 

$

0.25

 

Acquired intangible amortization

 

0.05

 

 

0.07

 

 

0.05

 

Tax adjustments

 

(0.01

)

 

(0.02

)

 

(0.01

)

Adjusted EPS (Non-GAAP)

$

0.28

 

$

0.25

 

$

0.29

 

Reconciliation of Net Earnings and Net Margin to Adjusted EBITDA (Non-GAAP) and

Adjusted EBITDA Margin (Non-GAAP):

Three Months Ended

6/30/2023

 

6/30/2022

 

3/31/2023

 

 

Net earnings

$

2,793

 

$

2,116

 

$

2,817

 

Acquired intangible amortization

 

523

 

 

765

 

 

544

 

Net interest expense

 

43

 

 

133

 

 

169

 

Income tax expense

 

572

 

 

454

 

 

577

 

Depreciation

 

259

 

 

174

 

 

245

 

Non-cash stock-based compensation

 

605

 

 

551

 

 

474

 

Adjusted EBITDA (Non-GAAP)

$

4,795

 

$

4,193

 

$

4,826

 

Revenue

 

32,558

 

 

29,571

 

 

31,919

 

Net margin

 

8.6

%

 

 

7.2

%

 

 

8.8

%

Adjusted EBITDA margin (Non-GAAP)

 

14.7

%

 

14.2

%

 

15.1

%

Reconciliation of Third Quarter 2023 Estimated Earnings Per Diluted Share to

Estimated Adjusted EPS (Non-GAAP):

 

Low

 

High

 

 

 

 

Estimated earnings per diluted share

$

0.20

 

 

$

0.24

 

Estimated acquired intangible amortization

 

0.04

 

 

 

0.04

 

Estimated tax adjustments

 

(0.01

)

 

 

(0.01

)

Estimated adjusted EPS (Non-GAAP)

$

0.23

 

 

$

0.27

 


« Previous Page 1 | 2 | 3 | 4 | 5  Next Page »



© 2024 Internet Business Systems, Inc.
670 Aberdeen Way, Milpitas, CA 95035
+1 (408) 882-6554 — Contact Us
ShareCG™ is a trademark of Internet Business Systems, Inc.

Report a Bug Report Abuse Make a Suggestion About Privacy Policy Contact Us User Agreement Advertise